Koraal TX B.V.

8 patents currently held · Updated Nov 15, 2026

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Ending by 2030

Apr 2034

Next term end

When these terms end

5 yrs10 yrs20 yrs

Held patents by the year their term ends

20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.

1 fee due Apr 3, 2027
The maintenance fee for Determination of MAPK-AP-1 Pathway Activity Using Unique Combination of Target Genes (US 11,776,661) comes due Apr 3, 2027. Unpaid by Oct 4, 2027, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 8 of 8

Patent	Title	Status	Expires	Confidence
US 11,443,831	Assessment of Cellular Signaling Pathway Activity Using Probabilistic Modeling of Target Gene Expression In force Term ends Apr 18, 2034 · Medium confidence	In force	Term ends Apr 18, 2034	Medium confidence
US 11,261,495	Assessment of the PI3K Cellular Signaling Pathway Activity Using Mathematical Modelling of Target Gene Expression In force Term ends Dec 30, 2034 · High confidence	In force	Term ends Dec 30, 2034	High confidence
US 10,016,159	Determination of Tgf-Beta Pathway Activity Using Unique Combination of Target Genes In force Term ends Oct 26, 2035 · High confidence	In force	Term ends Oct 26, 2035	High confidence
US 11,306,360	Assessment of Cellular Signaling Pathway Activity Using Linear Combination(S) of Target Gene Expressions In force Ends no later than Nov 14, 2035 · Medium confidence	In force	Ends no later than Nov 14, 2035	Medium confidence
US 11,450,409	DETERMINATION OF NFkB PATHWAY ACTIVITY USING UNIQUE COMBINATION OF TARGET GENES In force Term ends Jan 7, 2039 · High confidence	In force	Term ends Jan 7, 2039	High confidence
US 11,649,488	Determination of JAK-STAT1/2 Pathway Activity Using Unique Combination of Target Genes In force Term ends Mar 17, 2042 · High confidence	In force	Term ends Mar 17, 2042	High confidence
US 12,125,561	Determination of JAK-STAT3 Pathway Activity Using Unique Combination of Target Genes In force Term ends Jun 26, 2042 · High confidence	In force	Term ends Jun 26, 2042	High confidence
US 11,776,661	Determination of MAPK-AP-1 Pathway Activity Using Unique Combination of Target Genes In force Term ends Aug 4, 2042 · High confidence	In force	Term ends Aug 4, 2042	High confidence

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Export every term end as CSV · Pro